Cytokine Levels in Conversion Disorder

This study has been completed.
Sponsor:
Information provided by:
Trakya University
ClinicalTrials.gov Identifier:
NCT00971360
First received: September 2, 2009
Last updated: October 19, 2010
Last verified: September 2009
  Purpose

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.


Condition Intervention
Conversion Disorder
Other: conversion disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Proinflammatory Cytokine Levels in Patients With Conversion Disorder

Resource links provided by NLM:


Further study details as provided by Trakya University:

Estimated Enrollment: 30
Study Start Date: September 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Conversion disorder Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder
Healthy control Other: conversion disorder
Proinflammatory cytokine levels in conversion disorder

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria:

  • Autoimmune disease
  • Neurological disease
  • Any organic disorder that could possibly affect proinflammatory cytokines
  • Pregnancy
  • Any drug usage within 2 weeks
  • Any active or passive immunization within 6 months
  • Any other DSM-IV axis I psychiatric disorder
  • Mental retardation
  • Developmental disorder of childhood
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00971360

Locations
Turkey
Trakya University Faculty of Medicine; Department of Psychiatry
Edirne, Turkey, 22030
Sponsors and Collaborators
Trakya University
  More Information

Publications:
Responsible Party: Trakya University Scientific Research Unit (TUBAB)
ClinicalTrials.gov Identifier: NCT00971360     History of Changes
Other Study ID Numbers: TUTFEK 2009/173
Study First Received: September 2, 2009
Last Updated: October 19, 2010
Health Authority: United States: Institutional Review Board
Turkey: Ethics Committee

Keywords provided by Trakya University:
conversion
cytokine
inflammation

Additional relevant MeSH terms:
Conversion Disorder
Hysteria
Dissociative Disorders
Somatoform Disorders
Mental Disorders
Histrionic Personality Disorder
Personality Disorders

ClinicalTrials.gov processed this record on September 14, 2014